The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested

Toxicology in Vitro

Volumn 22, Issue 1, 2008, Pages 232-239

  Ulukaya, Engin ^a   Ozdikicioglu, Ferda ^a   Oral, Arzu Yilmaztepe ^a   Demirci, Meral ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

A549; ATP Assay; Chemotherapeutics; Cytotoxicity; In vitro; MTT Assay

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 HYDROPEROXYCYCLOPHOSPHAMIDE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; PACLITAXEL;

ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; INTERMETHOD COMPARISON; TOXICITY TESTING;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; LUNG NEOPLASMS; REPRODUCIBILITY OF RESULTS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 37249010159     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.08.006     Document Type: Article

References (32)

1. Ahmad S., Ahmad A., Schneider K.B., and White C.W. Cholesterol interferes with the MTT assay in human epithelial-like (A549) and endothelial (HLMVE and HCAE) cells. Int. J. Toxicol. 25 (2006) 17-23
2. Andreotti P.E., Cree I.A., Kurbacher C.M., Hartmann D.M., Linder D., Harel G., Gleiberman I., Caruso P.A., Ricks S.H., Untch M., Sartori C., and Bruckner H.W. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian cancer. Cancer Res. 55 (1995) 5276-5282
3. Andreotti P.E., Thornthwaite J.T., and Morse I.S. ATP tumor chemosensitivity assay. In: Stanley P.E., and Kricka L.J. (Eds). Bioluminescence and Chemiluminescence: Current Status (1991), John Wiley, Chiester 417-420
4. Atlante A., Giannattasio S., Bobba A., Gagliardi S., Petragallo V., Calissano P., Marra E., and Passarella S. An increase in the ATP levels occurs in cerebella granule cells en route to apoptosis in which ATP derives from both oxidative phosphorylation and anaerobic glycolysis. Biochim. Biophys. Acta 1708 (2005) 50-62
5. Cree I.A., Kurbacher C.M., Untch M., Sutherland L.A., Hunter E.M., Subedi A.M.C., James E.A., Dewar J.A., Preece P.E., Andreotti P.E., and Bruckner H.W. Correlation of clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity. Anticancer Drugs 7 (1996) 630-635
6. Cree I.A., and Andreotti P.E. Measurement of cytotoxicity by ATP-based luminescence assay in primary cell cultures and cell lines. Toxicol. In Vitro 11 (1997) 553-556
7. Eirheim H.U., Bundgaard C., and Nielsen H.M. Evaluation of different toxicity assays applied to proliferating cells and to stratified epithelium in relation to permeability enhancement with glycocholate. Toxicol. In Vitro 18 (2004) 649-657
8. Furukawa S. In vitro chemosensitivity of hepatocellular carcinoma for hepatic arterial infusion chemotherapy using the MTT assay with the combinations of antitumor drugs. Kurume Med. J. 51 (2004) 25-33
9. Garcia O., and Massieu L. Glutamate uptake inhibitor L-Trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production. J. Neurosci. Res. 74 (2003) 956-966
10. Green P.S., Perez E.J., Calloway T., and Simpkins J.W. Estradiol attenuation of beta-amyloid-induced toxicity: a comparison. J. Neurocytol. 29 (2000) 419-423
11. Hanauske AR. In vitro assays for antitumor activity: more pitfalls to come?. Eur. J. Cancer 29A (1993) 1502-1503
12. Hazary R.C., Chaudhuri D., and Wishart G.J. Application of an MTT reduction assay for assessing sperm quality and predicting fertilising ability of domestic fowl semen. Br. Poult. Sci. 42 (2001) 115-117
13. Hunter E.M., Sutherland L.A., Cree I.A., Subedi A.M.C., Hartmann D., Linder D., and Andreotti P.E. The influence of storage on cytotoxic drug activity in an ATP-based chemosensitivity assay. Anticancer Drugs 5 (1994) 171-176
14. Jabbar S.A.B., Twentyman P.R., and Watson J.V. The MTT assay underestimates the growth inhibitory effects of interferons. Br. J. Cancer 60 (1989) 523-528
15. Kerokoski P., Soininen H., and Pirttila T. Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality. Neurochem. Int. 38 (2001) 127-134
16. Kurbacher C.M., Cree I.A., Bruckner H.W., Brenne U., Kurbacher J.A., Muller K., Ackermann T., Gilster T.J., Wilhelm L.M., Engel H., Mallmann P.K., and Andreotti P.E. Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anticancer Drugs 9 (1998) 51-57
17. Kurbacher C.M., and Cree I.A. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements. Meth. Mol. Med. 110 (2005) 101-120
18. Liu Y., Song X.D., Liu W., Zhang T.Y., and Zuo J. Glucose deprivation induces mitochondrial dysfunction and oxidative stress in PC12 cell line. J. Cell Mol. Med. 7 (2003) 49-56
19. Maehara Y., Anai H., Tamada R., and Sugimachi K. The ATP assay is more sensitive than the succinate-dehydrogenase inhibition test for predicting cell viability. Eur. J. Cancer Clin. Oncol. 23 (1987) 273-276
20. + and ATP-stimulated rodent cortex synaptosomes. Neurosci. Res. Commun. 27 (2000) 103-107
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65 (1983) 55-63
22. Mueller H., Kassack M.U., and Wiese M. Comparison of the usefulness of the MTT, ATP and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines. J. Biomol. Screen. 9 (2004) 506-515
23. Nakamura R., Saikawa Y., Kubota T., Kumagai A., Kiyota T., Ohashi M., Yoshida M., Otani Y., Kumai K., and Kitajima M. Role of the MTT chemosensitivity test in the prognosis of gastric cancer patients after postoperative adjuvant chemotherapy. Anticancer Res. 26 (2006) 1433-1437
24. Pagliacci M.C., Spinozzi F., Migliorati G., Fumi G., Smacchia M., Grignani F., Riccardi C., and Nicoletti I. Genistein inhibits tumor-cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts - a further pitfall in the use of the MTT assay for evaluating cell-growth and survival. Eur. J. Cancer 29A (1993) 1573-1577
25. Petty R.D., Sutherland L.A., Hunter E.M., and Cree I.A. Comparison of MTT and ATP-based assays for the measurement of viable cell number. J. Biolumin. Chemilumin. 10 (1995) 29-34
26. Sevin B.U., Perras J.P., Averette H.E., Donato D.M., and Penalver M. Chemosensitivity testing in ovarian cancer. Cancer 71 (1993) 1613-1620
27. Taylor C.G., Sargent J.M., Elgie A.W., Williamson C.J., Lewandowicz G.M., Chappatte O., and Hill J.G. Chemosensitivity testing predicts survival in ovarian cancer. Eur. J. Gynaecol. Oncol. 22 (2001) 278-282
28. Ulukaya E., Colakogullari M., and Wood E.J. Interference by anti-cancer chemo - therapeutic agents in the MTT - tumor chemosensitivity assay. Chemotherapy 50 (2004) 43-50
29. Weyermann J., Lochmann D., and Zimmer A.A. Practical note on the use of cytotoxicity assays. Int. J. Pharm. 288 (2005) 369-376
30. Wilson J.K., Sargent J.M., Elgie A.W., Hill J.G., and Taylor C.G. A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy. Br. J. Cancer 62 (1990) 189-194
31. Wochna A., Niemczyk E., Kurono C., Masaoka M., Majczak A., Kedzior J., Slominska E., Lipinski M., and Wakabayashi T. Role of mitochondria in the switch mechanism of the cell death mode from apoptosis to necrosis - studies on p degrees cells. J. Electron. Microsc. 54 (2005) 127-138
32. Yang M.S., Tse W.K.F., Yu L.C., Li K.M., and Mak N.K. Energy and redox states in the C6 glioma cells following acute exposure to Zn, Se+4, and Se+6 and the correlation with apoptosis. Toxicol. Mech. Meth. 16 (2006) 13-19